Author:
Wu Lung-Sheng,Chang Shang-Hung,Chang Gwo-Jyh,Liu Jia-Rou,Chan Yi-Hsin,Lee Hsin-Fu,Wen Ming-Shien,Chen Wei-Jan,Yeh Yung-Hsin,Kuo Chi-Tai,See Lai-Chu
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. American Diabetes Association. Standards of Medical Care in Diabetes-2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
2. KDOQI. KDOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–154.
3. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to Eight Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
4. Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, et al. Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet. 2015;385(9982):2047–56.
5. Padwal R, Lin M, Eurich DT. The comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers in patients with diabetes. J Clin Hypertens. 2015. doi: 10.1111/jch.12647 .
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献